Mar 1, 2018 4:30 pm EST Achieve Announces Recent Highlights and Reports Year-End 2017 Financial Results
Feb 20, 2018 5:30 am EST Achieve Announces Preliminary Data from Cytisine Phase I/II Multi-Dose, Pharmacokinetic and Pharmacodynamics (PK/PD) Clinical Study
Jan 24, 2018 5:30 am EST Achieve Announces Expansion of Partnership with the University of Bristol for Next Generation Cytisine-Based Therapies to Include Exclusive Rights for Cytisine Development Across Multiple Therapeutic Categories
Nov 28, 2017 5:30 am EST Achieve Announces Clinical Trial Supply and Cooperation Agreement with the University of Auckland for the Evaluation of Cytisine Compared to Varenicline for Smoking Cessation
Nov 14, 2017 5:30 am EST Achieve Announces Results of Clinical Study Demonstrating Similar Bioavailability of Cytisine in Fed and Fasted Subjects
Nov 8, 2017 5:30 am EST Achieve to Present at the 29th Annual Piper Jaffray Healthcare Conference on November 28th, 2017
Nov 6, 2017 8:31 am EST Achieve Announces Availability of Company Presentation from the Virtual Investor Conference
Oct 30, 2017 8:31 am EDT Achieve Announces Company Presentation at Virtual Investor Conference on November 2, 2017
Oct 26, 2017 5:30 am EDT Achieve Announces Exclusive, Long-term Manufacturing Agreement with Sopharma for Clinical and Commercial Supply of Cytisine